(Q51581781)

7 April 2018

title

Glucose intolerance in thalassemia major is related to insulin resistance and hepatic dysfunction. (English)

1 reference

7 April 2018

1 reference

1 reference

1 reference

Pappas S

1

1 reference

7 April 2018

Donohue SM

2

1 reference

7 April 2018

Denver AE

3

1 reference

7 April 2018

Mohamed-Ali V

4

1 reference

7 April 2018

Goubet S

5

1 reference

7 April 2018

Yudkin JS

6

1 reference

7 April 2018

publication date

1 May 1996

1 reference

7 April 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

7 April 2018

volume

45

1 reference

7 April 2018

issue

5

1 reference

7 April 2018

page(s)

652-657

1 reference

7 April 2018

Abnormal glucose tolerance in beta-thalassemia major

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Insulin Resistance and Iron Overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Survival and causes of death in thalassaemia major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Insulin dependent diabetes in thalassaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Transection of the oesophagus for bleeding oesophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Metabolic handling of orally administered glucose in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Glucose tolerance and diabetes in chronic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Glucose, Insulin and Somatostatin Infusion for the Determination of Insulin Resistance in Liver Cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

Glucose metabolism in cirrhosis: a review with some perspectives for the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990038-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(96)90038-4

1 reference

7 April 2018

1 reference

7 April 2018